glp 1 treatment diabetes Beyond Blood Glucose: How GLP-1s are Changing Management GLP-1-based therapies for diabetes, obesity

Quick Answer: Semaglutide does not directly cause urine odor changes, but the metabolic effects of weight loss, ketosis, dehydration, and dietary modifications during treatment can indirectly alter urine smell

Polycystic ovary syndrome (PCOS) : Approximately 4080% of women with PCOS are overweight or obese

Adaptation to the medications, requiring higher and higher doses to maintain the same satiety effects Individual biologic differences, leading to different effects of GLP medications than the norm

Tirzepatide (Mounjaro, Zepbound) Unopened: Refrigerate at 36F46F (2C8C) until first use

Effect of semaglutide on cardiac structure and function in patients with obesity-related heart failure

However, there is also a possibility that some of the effect may be independent of GLP-1, because DPP-4 inhibition still reduced -cell apoptosis in human islets cultured in the presence of exendin 9-39 (99), suggesting that other mediators might be involved, but it was also suggested that an anti-inflammatory action could have played a role (99)